Key facts:
Authors: Natalie Acors and Peter Glennon
Top Tip: If the ventricular rate cannot be controlled easily, atrial fibrillation is probably not the primary problem - ie find the 'cause'
|
Key Differential Diagnoses |
Atrial flutter |
|
Key Investigations |
FBC, ESR, CRP |
|
Key Treatment |
PO BISOPROLOL 5 mg od (not if asthmatic), or |
|
Key Management Decision |
DC cardioversion (if new, and <24h) |
Background
AF is the commonest arrythmia. It is very common, many don't know they have it
|
Introduction |
• Atrial fibrillation is an ineffective, chaotic, irregular, rapid rhythm. The atrial rate is usually 300 beats/min; resulting in irregular ventricular rate, as impulses approach AVN from varying angles, at varying intervals • The ventricular rate is variable, depending on how may impulses are transmitted to the ventricles, leading to ventricular contraction. So the clinical syndrome can be a bradycardia, or a tachycardia (or a normal heart rate) • So, to be pedantic, 'Slow' and 'Fast' AF do not really exist as the atrial rate is always fast. Nonetheless, like most clinicians, the authors also use these terms • To confuse things further, the ventricular rate that can be detected at the apex with a stethoscope (or ECG) is often greater than the rate that can be felt at the radial pulse. It is better, therefore, to report the ventricular rate • Apart from rate control, anticoagulation is often necessary • Causes and treatment of atrial flutter are similar. It is not a benign disease; mortality at 1y is 8% in one study • The CHADS2 Score (see below) has been developed to help you decide whether to anticoagulate or not |
| Embolisation | • AF is usually associated with enlargement of the left atrium. This results in turbulence and stasis of blood which in turn predisposes to thrombus formation, especially in the atrial appendage • Apart from heart failure, the most important consequence is that a thrombus may embolise (from the atria) to any part of the peripheral circulation: resulting in a TIA or CVA; or infarction of a major viscus - eg bowel infarction (usually missed, and thus fatal) • Embolisation from thrombi in the right atrium may result in PE • So, for these reasons, it is a more serious disease than you would think. Nonetheless, as 2/3rds of patients with AF resolve spontaneously in the first 24 hrs, it is not always essential to act immediately - especially if the patient is well |
|
Definition |
An atrial rhythm, originating from multiple atrial foci |
|
Epidemiology |
> 65 yrs = 5%; >75 yrs = 10% |
|
Types |
Paroxysmal (50%), Acute or Chronic |
|
Causes |
Apart from idiopathic ('lone AF'), there are 3 important causes: |
|
Symptoms |
Very variable |
|
Key questions |
"When did the symptoms start?" |
|
Signs |
Very variable |
Investigation
|
Blood |
FBC, CRP |
|
Other |
CXR |
|
Key investigation |
ECG
|
|
Specialist investigation |
ECHO |
|
Differential diagnosis |
Other causes of an irregularly irregular pulse: |
Treatment
The three therapeutic goals in AF are: cardioversion (if possible), control of ventricular rate (if not) and the prevention of thromboembolism
|
Treatment atrial fibrillation |
Drugs |
| Indications for WARFARIN |
This is a controversial area. The dangers of warfarin are probably outweighed by its benefits (mainly CVA prevention) if the patient has CCF, DM, structural heart disease, BP, prev CVA/TIA, or is >75y (see NICE guidelines in references). The CHADS2 score has been developed to help: |
|
Key management decision |
DC cardioversion/not |
|
Stop |
Antiarrthymic, if thought to be cause (specialist decision) |
|
Treatment |
IV AMIODARONE 5 mg/kg over 20-120 mins, via central line, with ECG monitoring; max 1.2 g over 24h |
| Prescribing issues | Loading dose of DIGOXIN same; but reduce maintenance dose in frail/elderly or renal failure (to 125 mcg or 62.5 mcg od) |
| Rhythm vs Rate Control | Another controversial area. There is an ongoing debate about the relative importance of reverting the rhythm to sinus (rhythm control) or controlling the ventricular rate (rate control). If the AF is of <48 hrs duration, the benefits of trying to revert it to SR (say with DC cardioversion) probably outweigh the risks of lifelong warfarin etc |
|
Admit? |
Usually, though if patient not in heart failure, OP management possible |
|
Bed plan? |
Medical admission ward, if uncomplicated |
|
Referrals |
Medical |
The Rest
2/3rds acute AF resolves spontaneously on first 24 hrs - ie sometimes it is better to do nothing, and wait
|
Complications |
Acute heart failure (rarely the cause) |
|
Prognosis |
• Mortality at 1y is 8% in one study |
|
Risk stratification, CVA (adapted from NICE, 06) |
High |
|
2° Prevention + Health promotion |
• Stay on warfarin (or aspirin, in frail elderly, or if patient has PH of Upper GI bleed), for life |
|
Don't forget |
• Look for underlying cause |
|
Red flags |
• Heart failure |

